Tag: TGEN
-
Artists and researchers pair up as part of next PBC collaborative art project
The Phoenix Bioscience Core and its PBC Arts Committee have announced the 10 teams of artists and researchers working together to develop a collaborative piece of art.
-
New TGen study details new understanding of Alzheimer’s disease
An international group of researchers, including TGen faculty, published a new paper that detail changes related to Alzheimer’s disease.
-
TGen, University of Wisconsin researchers use machine learning to make early detection of cancer more accessible
TGen and University of Wisconsin researchers published a study to make early cancer detection more available.
-
New TGen research expands options for treating medulloblastoma
A deep dive into the proteins and protein activities of human tumors grown in mouse models expands the potential therapeutic pathways to treat medulloblastoma, according to a new study published in the Journal of Proteome Research.
-
TGEN part of $2 million SBIR award to fund therapeutic development and testing
The Translational Genomics Research Institute (TGen), and Stingray Therapeutics, Inc. of Dallas and Houston, Texas announced a Small Business Innovation Research (SBIR) accelerated direct to phase II award of $2 Million.
-
TGen, Arizona State University collaborate to treat fatty liver disease in Latino youth through NIDDK grant
Arizona State University’s Edson College of Nursing and Health Innovation, Phoenix Children’s Hospital and the Translational Genomics Research Institute (TGen) announced yesterday they will partner on a new study along with Cincinnati Children’s focused on nonalcoholic fatty liver disease, or NAFLD, in Latino youth.
-
TGen adds to C-Suite, appoints Page Bachman as Chief People Office
The Translational Genomics Research Institute (TGen), part of City of Hope, today announced the appointment of Page Bachman, JD, as the Institute’s Senior Vice President of Human Resources and Chief People Officer.
-
TGen, City of Hope receive gift from Lynda Carter Altman to fund blood cancer diagnostics, treatment
PHOENIX, September 8, 2022 — The Translational Genomics Research Institute (TGen), part of City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced a […]
-
New TGen research finds link in severity for Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is both increasingly common and potentially deadly; yet its causes remain poorly understood. Now, a collaborative team of researchers at the Translational Genomics Research Institute (TGen), part of City of Hope, and Temple University has uncovered a link between decreases in an enzyme that makes choline in the liver —an…
-
TGen names Kevin Campbell new CIO
The Translational Genomics Research Institute (TGen), part of City of Hope, today announced that industry veteran Kevin Campbell has been appointed the Institute’s Chief Information Officer.
